In a person who has type 1 diabetes (T1D), immune cells destroy the insulin-producing beta cells in the pancreas. However, right after the time of diagnosis, some people experience a “honeymoon phase” in which their existing beta cells still function and the body is able to produce its own insulin. Halting the autoimmune response in people with new onset T1D and those who are at risk is one of the chief areas of research JDRF is focused on. JDRF funds a number of efforts to curb the progression of T1D in newly diagnosed individuals. A number of research projects funded by JDRF have shown promise in preserving the function of these existing beta cells in people with T1D past the honeymoon phase.